Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Primer, probe and method for screening MLL-SEPT6 fusion gene of leukemia with real-time fluorescence PCR (polymerase chain reaction) technology

A technology that combines genes and real-time fluorescence, applied in the field of biotechnology detection, can solve the problems that karyotype analysis cannot meet MRD, cannot meet sensitivity at the same time, and has many PCR reaction systems, so as to avoid hematological recurrence, save detection time, and prevent The effect of clinical recurrence

Active Publication Date: 2017-12-08
北京艾迪康医学检验实验室有限公司
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Secondly, in some cases, the chromosomal translocations are complex and tiny, which cannot be analyzed by naked eyes
Furthermore, karyotype analysis cannot meet the needs of MRD (Minimal Residual Disease, minimal residual disease) detection
However, the method of multiple nested PCR combined with electrophoresis is time-consuming, cumbersome, easily polluted, the judgment of the result is more subjective, and there are many PCR reaction systems and high cost, so it is not suitable for high-throughput sample detection
It can only perform qualitative detection, and cannot meet the needs of high sensitivity and specificity at the same time

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Primer, probe and method for screening MLL-SEPT6 fusion gene of leukemia with real-time fluorescence PCR (polymerase chain reaction) technology
  • Primer, probe and method for screening MLL-SEPT6 fusion gene of leukemia with real-time fluorescence PCR (polymerase chain reaction) technology
  • Primer, probe and method for screening MLL-SEPT6 fusion gene of leukemia with real-time fluorescence PCR (polymerase chain reaction) technology

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0040]The method is used as an auxiliary indicator for early prevention and early diagnosis of human leukemia in clinic; it can also be used for relatively accurate screening of high-risk groups. Reagents include: erythrocyte lysate, TRIzol, chloroform, absolute ethanol, ReverTra Ace qPCR RT Kit (TOYOBO).

[0041] Detection system PCR reaction solution: ReverTra AceqPCR RT Kit (TOYOBO); THNDERBIRDProbe qPCR Mix (2×), MLL-SEPT6 upstream and downstream primers 0.32uM, MLL-SEPT6 probe 0.16uM; abl upstream and downstream primers 0.32uM , abl-probe (probe) 0.16uM; Wherein:

[0042] MLL(exon9)-F:GAACATCCTCAGCACTCTCTCC;

[0043] MLL(exon10)-F:TTGACTTCTGTTCCTATAACACCC;

[0044] MLL(exon11)-F:AAATTGGTGTTGTCGTCGTTG;

[0045] SEPT6(exon2)-R:CAAGCTGTCAAAACCCCACAT;

[0046] MLL-SEPT6-Probe:FAM-CCGAACTGTCCCCCCTGGCTG-TAMRA;

[0047] abl-F:GATACGAAGGGAGGGTGTACCA;

[0048] abl-R:CTCGGCCAGGGTGTTGAA;

[0049] abl-Probe:FAM-GCTTCTGATGGCAAGCTCTACGTCTCCT-TAMRA;

[0050] Positive control sub...

Embodiment 2

[0052] The operation flow of this method:

[0053] (1) Extract tissue RNA from blood: add 1ml of erythrocyte lysate to a clean 1.5ml centrifuge tube, take 0.5ml of anticoagulated blood and mix well. Let stand at room temperature for 10 minutes; centrifuge at 5000rpm for 5min, discard the supernatant, and collect the cells at the bottom; add 0.5ml red blood cell lysate again, centrifuge at 5000rpm for 5min, discard the supernatant, and collect the cells at the bottom; add 1ml TRIzol to the cells, and pipette repeatedly until the precipitation is complete Dissolve, let stand at room temperature for 5 minutes; add 0.2ml chloroform, shake evenly; centrifuge at 14000rpm at 4°C for 10 minutes, absorb the supernatant layer and transfer to another new centrifuge tube; add an equal volume of isopropanol, mix well up and down, and let stand at room temperature for 10 minutes Centrifuge at 14000rpm at 4°C for 10min, discard the supernatant, add 1ml of 75% ethanol, wash the tube wall upsi...

Embodiment 3

[0063] Clinical Sample Testing

[0064] Take 12 clinical samples to be tested, extract genomes, prepare reagents and detect according to the method described in Example 2.

[0065] Add 2ul of each sample to the detection system PCR reaction solution. At the same time, make positive, negative, and blank controls. Detect with a fluorescent PCR instrument for 100 minutes. The abl of all samples in the 12 screening samples had a line, but none of the samples of MLL exon9-SEPT6 exon2, MLL exon10-SEPT6 exon2 and MLL exon11-SEPT6 exon2 had a line.

[0066] The experimental results are as follows:

[0067]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a method for detecting the relative expression quantity of an MLL-SEPT6 fusion gene with a fluorescence quantitative PCR (polymerase chain reaction) technology. The method comprises a specific premier and a probe that are used for screening minimal residues of the MLL-SEPT6 fusion gene in bodies of leukemia patients, so that the method has significance in the aspects of avoiding hematologic relapse through timely intervention treatment, adjusting a therapeutic schedule, evaluating a treatment effect, predicting prognosis and preventing clinical relapse.

Description

technical field [0001] The invention belongs to the field of biotechnology detection, and particularly relates to a method for screening fusion genes, which uses probe Taqman real-time fluorescent PCR technology to detect the situation of MLL-SEPT6 fusion genes in human leukemia patients. Background technique [0002] Leukemia is a kind of clonal malignant disease with abnormal hematopoietic stem cells. The leukemia cells in its clones lose the ability to further differentiate and mature and stagnate at different stages of cell development. In the bone marrow and other hematopoietic tissues, a large number of leukemia cells proliferate and accumulate and infiltrate other organs and tissues, and at the same time inhibit normal hematopoiesis. The clinical manifestations are anemia, bleeding, infection and infiltration of various organs. The etiology and pathogenesis of human leukemia are still not fully understood. The known causes include infectious factors, ionizing radiat...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/68C12N15/11
CPCC12Q1/6848C12Q1/6886C12Q1/686C12Q2600/158C12Q2561/113C12Q2563/107C12Q2545/114C12Q2561/101
Inventor 桑志高吴鹏飞王淑一
Owner 北京艾迪康医学检验实验室有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com